Caris Life Sciences Income Statement (2024-2026) | CAI

Income Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 100.05M101.62M129.91M120.92M181.40M216.83M292.89M216.17M
Cost of Revenue (Quarter) 3.06M54.81M3.27M60.89M65.32M66.98M254.66M1.94M
Gross Profit (Quarter) 96.98M46.81M126.64M60.02M116.08M149.85M38.23M214.23M
Operating items
Research & Development (Quarter) 38.71M36.76M65.80M39.83M42.26M21.62M31.84M45.04M
Selling, General & Administrative (Quarter) 41.07M40.85M43.11M52.12M64.37M51.97M56.51M59.71M
Other Operating Expenses (Quarter) 87.28M84.85M58.05M86.92M92.76M110.59M116.12M106.14M
Operating Expenses (Quarter) 167.06M162.46M166.96M178.87M199.39M184.19M204.47M210.89M
Operating Income (Quarter) -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M
EBIT (Quarter) -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M
Non-operating items
Interest & Investment Income (Quarter) 2.64M1.74M0.97M0.50M1.62M7.36M7.01M6.83M
Other Non Operating Income (Quarter) -0.14M0.04M-0.03M-0.02M-18.34M-0.09M-2.11M0.05M
Non Operating Income (Quarter) 0.82M-6.89M0.10M-44.63M-53.80M-8.32M-6.45M-5.93M
Net income details
EBT (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.64M
Tax Provisions (Quarter) -0.13M
Profit After Tax (Quarter) -66.09M-67.85M-36.95M-102.55M-517.20M24.32M81.96M-0.51M
Income from Continuing Operations (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Consolidated Net Income (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Income towards Parent Company (Quarter) -66.19M-67.73M-36.95M-102.58M-71.79M24.32M81.96M-0.51M
Preferred Dividend Payments (Quarter) 96.37M24.46M60.97M
Net Income towards Common Stockholders (Quarter) -89.78M-92.39M-61.95M-127.04M-517.20M24.32M81.96M-0.51M
Additional items
EPS (Basic) (Quarter) -2.54-2.59-1.75-3.57-7.970.090.490.00
EPS (Diluted) (Quarter) -2.54-2.59-1.75-3.57-7.970.080.490.00
Shares Outstanding (Quarter) 35.37M35.64M35.50M35.62M64.92M282.10M167.21M282.56M
Shares Outstanding (Diluted) (Quarter) 35.37M35.64M35.50M35.62M64.92M297.21M167.21M282.56M
EBITDA (Quarter) -67.01M-60.84M-37.05M-57.95M-17.99M32.64M88.41M5.28M
Interest Expenses (Quarter) 13.67M13.80M-25.47M12.78M348.61M450.46M-1.98M12.81M
Tax Rate (Quarter) 20.81%